Evidence mapPaperPMID 41336283Full record

ArticlePloS one2025

Translocation of benzo(a)pyrene reactive metabolites across human mammary epithelial cell membranes.

B Alex Merrick, Ashley M Brooks, Julie F Foley, Betty K Mansfield, James K Selkirk

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

B Alex MerrickMechanistic Toxicology Branch, Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States of America.ORCID https://orcid.org/0000-0001-7792-2597
Ashley M BrooksIntegrative Bioinformatics Support Group, Biostatistics and Computational Biology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States of America.ORCID https://orcid.org/0000-0003-2242-5942
Julie F FoleyMechanistic Toxicology Branch, Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States of America.
Betty K MansfieldNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States of America.
James K SelkirkNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA adducts from benzo(a)pyrene (BaP) and other polycyclic aromatic hydrocarbons (PAH) are related to tumor initiation in many tissues including mammary epithelia. T47D mammary cells are able metabolizers of BaP, forming DNA and cellular protein adducts but also a sizeable amount of extracellular protein adducts. GSH S-transferases (GST) help mitigate adduct formation by glutathione (GSH) conjugation. Here, we varied GSH levels using buthionine sulfoximine (BSO) and BaP pretreatments to deplete or augment GSH, respectively, to study adduct formation and metabolism at 4 µM 3H-BaP over 24-48hr. An inverse relationship was observed between GSH levels and nuclear protein and DNA adducts. Time course experiments showed extracellular protein adducts, identified primarily as bovine serum albumin and α1-AT (α-1-antitrypsin) in culture medium, were 5-10 times greater than cellular protein adducts and comprised 8-9% of total metabolized 3H-BaP. However, specific adduct binding (adducts/mg protein) in cells was much greater than for extracellular protein, likely from their intracellular proximity to CYP-mediated metabolism to BaP reactive metabolites. Proportions of 3H-BaP hydroxylated and conjugated metabolites in BSO and BaP pretreated cells were not greatly altered from DMSO control after 24 hr. Bioinformatic analysis of T47D cell gene expression indicated CYP1B1 and CYP1A1 were primary enzymes for BaP bioactivation. We surmised reactive BaP metabolites that escaped conjugation reactions were sufficiently stable to migrate into the extracellular space. These results suggest BaP reactive metabolites like BPDE (BaP-diol-epoxide) can easily translocate across cell membranes despite robust conjugation systems and ready supplies of essential co-substrates for sulfate or GSH conjugations. The implications in vivo are that BaP reactive metabolites can enter adjacent epithelia and some fraction could result in DNA binding and somatic mutations in cancer susceptibility genes over time. The relationship continues to grow between PAH exposure and pollution, and many malignancies including breast cancers.

Indexed as

Benzo(a)pyreneCell MembraneEpithelial CellsMammary Glands, HumanButhionine SulfoximineCell Line, TumorCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1DNA AdductsFemaleGlutathioneHumansBenzo(a)pyreneButhionine SulfoximineCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1DNA AdductsGlutathione

Identifiers

PMID41336283
PMCPMC12674524

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.